# Clinical context A 68-year-old with chronic kidney disease and heart failure is starting sodium zirconium cyclosilicate for persistent hyperkalemia and takes several time-sensitive oral medicines. Which teaching points are appropriate for a client taking sodium zirconium cyclosilicate? Select exactly 4 responses.

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=603009&lang=en  
> language: en  
> subject: Adverse Effects/Contraindications/Interactions  
> category: PPT

## Question

Clinical context
A 68-year-old with chronic kidney disease and heart failure is starting sodium zirconium cyclosilicate for persistent hyperkalemia and takes several time-sensitive oral medicines.

Which teaching points are appropriate for a client taking sodium zirconium cyclosilicate? Select exactly 4 responses.

Select exactly 4 responses.

1

Report increasing edema or rapid weight gain.

2

Review sodium load and fluid status when heart failure or edema risk is present.

3

Use it as the sole emergency treatment for life-threatening hyperkalemia because it works immediately.

4

Mix the powder with water and drink it promptly as directed.

5

Separate other oral medications by at least 2 hours when gastric pH changes could affect absorption.

6

Begin scheduled potassium chloride with each dose because mild hypokalemia is expected after treatment starts.

## Explanation

Sodium zirconium cyclosilicate has a delayed onset and is not emergency monotherapy. It can cause edema because each dose contains sodium and can affect absorption of pH-dependent oral drugs.

## In-depth explanation

Quick answer
Remember two-hour spacing, water mixing, delayed onset, and edema surveillance.

Why this is correct
A potassium binder can support ongoing control but does not replace immediate membrane stabilization and intracellular shifting when hyperkalemia is life-threatening.

Easy analogy or mental picture
Build a medication-safety chain: identify the new cue, connect it to the drug mechanism or labeled limitation, stop preventable exposure, stabilize the client, and verify a measurable response.

Memory hook
Drug, urgent cue, protective action, and reassessment endpoint.

NCLEX decision rule
Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.

Why the other choices are wrong
Options that continue a suspect exposure, normalize a labeled danger cue, substitute an unauthorized dose, or delay escalation leave the client at risk.References
1DailyMed: LOKELMA (sodium zirconium cyclosilicate)Delayed onset, oral-drug separation, sodium content, and edema

## Clinical scenario

Clinical context
A 68-year-old with chronic kidney disease and heart failure is starting sodium zirconium cyclosilicate for persistent hyperkalemia and takes several time-sensitive oral medicines.

## Related questions

- [A client is admitted to the emergency department after ingesting an unknown amount of acet…](https://mymerci.kr/pages/nclex_q.php?qn_id=362720&lang=en)
- [A client with chronic heart failure is prescribed metoprolol 25 mg orally twice daily. Bef…](https://mymerci.kr/pages/nclex_q.php?qn_id=362756&lang=en)
- [A 28-year-old client with type 1 diabetes receives regular insulin 6 units and NPH insulin…](https://mymerci.kr/pages/nclex_q.php?qn_id=362792&lang=en)
- [A client receives IV vancomycin 1 g every 12 hours for MRSA bacteremia. Before the next do…](https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=en)
- [A client with bipolar disorder has been taking lithium carbonate 600 mg orally three times…](https://mymerci.kr/pages/nclex_q.php?qn_id=362894&lang=en)
- [A nurse is monitoring a client receiving a continuous IV heparin infusion for pulmonary em…](https://mymerci.kr/pages/nclex_q.php?qn_id=363988&lang=en)
- [A nurse is preparing to initiate a weight-based continuous IV unfractionated heparin infus…](https://mymerci.kr/pages/nclex_q.php?qn_id=364107&lang=en)
- [A nurse is providing discharge teaching to a 65-year-old client newly prescribed warfarin …](https://mymerci.kr/pages/nclex_q.php?qn_id=364872&lang=en)

## Read in another language

- [en](https://mymerci.kr/pages/nclex_q.php?qn_id=603009&lang=en)
- [ko](https://mymerci.kr/pages/nclex_q.php?qn_id=603009&lang=ko)
- [ja](https://mymerci.kr/pages/nclex_q.php?qn_id=603009&lang=ja)
- [zh-TW](https://mymerci.kr/pages/nclex_q.php?qn_id=603009&lang=zh-tw)
- [vi](https://mymerci.kr/pages/nclex_q.php?qn_id=603009&lang=vi)

---

More free questions: [NCLEX-RN Practice](https://mymerci.kr/pages/nclex_bank.php?lang=en)

_For study reference only. Always follow current clinical guidelines and your institution’s protocols._